Colistimethate Sodium

Chemical Name: Sodium N-(methylpropanoyl)-N-[(4R,5R,6S)-5-{[(3R,6R,9S,12R,15S,18R,21S)-18-(4-amino-1H-imidazol-5-yl)-15-benzyl-9-(1H-indol-3-ylmethyl)-6-(1H-tetrazol-5-yl)-12-(1H-tetrazol-5-yl)-3-(1H-tetrazol-5-yl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosan-21-yl]pentanamido}-6-(1H-tetrazol-5-yl)hexanamide sulfate

CAS Number: 8068-37-9

Colistimethate Sodium is indicated for the treatment of acute or chronic infections caused by susceptible strains of gram-negative bacteria, especially those caused by Pseudomonas aeruginosa. Its clinical efficacy has been confirmed for infections caused by Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. It is also suitable for initial treatment of severe infections suspected to be caused by gram-negative bacteria, and for the treatment of infections caused by susceptible gram-negative bacteria.

Colistimethate Sodium meets the standards of EP, USP, and other international pharmacopeias. The product has obtained European CEP certification.